Liver Transplantation for Tyrosinemia Type 1 in the Developing World: Is It Really the Best We Can Offer?: Authors' Reply
- PMID: 35731498
- DOI: 10.1007/s12098-022-04230-z
Liver Transplantation for Tyrosinemia Type 1 in the Developing World: Is It Really the Best We Can Offer?: Authors' Reply
Comment on
-
Liver Transplantation for Tyrosinemia Type 1 in the Developing World: Is It Really the Best We Can Offer?Indian J Pediatr. 2022 May;89(5):427-428. doi: 10.1007/s12098-022-04128-w. Epub 2022 Mar 9. Indian J Pediatr. 2022. PMID: 35262865 No abstract available.
-
Liver Transplantation for Tyrosinemia Type 1 in the Developing World: Is It Really the Best We Can Offer?: Correspondence.Indian J Pediatr. 2022 Aug;89(8):839. doi: 10.1007/s12098-022-04229-6. Epub 2022 Jun 15. Indian J Pediatr. 2022. PMID: 35704214 No abstract available.
References
-
- Menon J, Shanmugam N, Rela M. Liver transplantation for tyrosinemia type 1 in the developing world: is it really the best we can offer?: correspondence. Indian J Pediatr. 2022. https://doi.org/10.1007/s12098-022-04229-6 .
-
- Vimalesvaran S, Souza LN, Deheragoda M, et al. Outcomes of adults who received liver transplant as young children. E Clin Med. 2021;38:100987.
-
- Mayorandan S, Meyer U, Gokcay G, et al. Cross-sectional study of 168 patients with hepatorenal tyrosinemia and implications for clinical practice. Orphanet J Rare Dis. 2014;9:107. - DOI
-
- Menon J, Shanmugam N, Valamparampil JJ, et al. Liver transplantation: a safe and definitive alternative to lifelong nitisinone for tyrosinemia type 1. Indian J Pediatr. 2021. https://doi.org/10.1007/s12098-021-03826-1 . - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
